Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.
Also called NCT01921322
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 118 participants
- Sponsor
- Registry
-
NCT01921322
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01921322. Randomized; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2015-05 (actual). Results posted on 2017-07-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy
- Condition
- Type 2 Diabetes
- Intervention (Device)
- Pump
- Intervention (Other)
- CGMS Gold
- Lead sponsor
- Medtronic MiniMed, Inc.
Record details
- Record id
cardio:ct-nct01921322- Content hash
f5e9a2cd76490025b5a8d55d188dc8a8564c0ba0b20b0cb41ba190aeb2a7fd65